Raymond James Financial
EDIT icon

Raymond James Financial’s Editas Medicine EDIT Stock Holding History

Raymond James Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.2M Buy
1,293,848
+109,178
+9% +$231K ﹤0.01% 2961
2025
Q4 		$2.43M Buy
1,184,670
+1,020,782
+623% +$2.95M ﹤0.01% 3104
2025
Q3 		$569K Sell
163,888
-18,230
-10% -$50.9K ﹤0.01% 4031
2025
Q2 		$401K Sell
182,118
-15,348
-8% -$25.1K ﹤0.01% 4134
2025
Q1 		$229K Sell
197,466
-41,501
-17% -$61K ﹤0.01% 4346
2024
Q4 		$303K Buy
+238,967
New +$609K ﹤0.01% 4178

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial's EDIT Position: Q1 2026 in Review

Raymond James Financial increased its Editas Medicine (EDIT) stake by 9.2% in Q1 2026, buying an estimated $231K and bringing the position to 1,293,848 shares worth $3.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

Raymond James Financial first reported a position in EDIT in Q4 2024 and has held it in 6 quarters since. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Raymond James Financial held 1,293,848 shares of Editas Medicine worth $3.2M as of Q1 2026.
  • Raymond James Financial bought 109,178 Editas Medicine shares in Q1 2026, an estimated $231K.
  • Editas Medicine made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2961 holding.
  • Raymond James Financial first reported a position in Editas Medicine in Q4 2024 and has held it in 6 quarters since.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.